RAY B Stock Overview
A medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 164.40 |
52 Week High | SEK 168.40 |
52 Week Low | SEK 78.40 |
Beta | 1.34 |
11 Month Change | 25.30% |
3 Month Change | 13.38% |
1 Year Change | 100.73% |
33 Year Change | 163.04% |
5 Year Change | 0.55% |
Change since IPO | 28,912.11% |
Recent News & Updates
Recent updates
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
May 21The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing
May 11RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends
Oct 04Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?
Jul 10Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?
Nov 17One Forecaster Is Now More Bearish On RaySearch Laboratories AB (publ) (STO:RAY B) Than They Used To Be
Mar 15Is RaySearch Laboratories (STO:RAY B) A Risky Investment?
Feb 22Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Nov 04Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Mar 30Shareholder Returns
RAY B | SE Healthcare Services | SE Market | |
---|---|---|---|
7D | 9.0% | 9.2% | -1.0% |
1Y | 100.7% | 66.0% | 18.6% |
Return vs Industry: RAY B exceeded the Swedish Healthcare Services industry which returned 60.3% over the past year.
Return vs Market: RAY B exceeded the Swedish Market which returned 18.7% over the past year.
Price Volatility
RAY B volatility | |
---|---|
RAY B Average Weekly Movement | 7.1% |
Healthcare Services Industry Average Movement | 5.3% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.6% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: RAY B has not had significant price volatility in the past 3 months.
Volatility Over Time: RAY B's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 411 | Johan Lof | www.raysearchlabs.com |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research.
RaySearch Laboratories AB (publ) Fundamentals Summary
RAY B fundamental statistics | |
---|---|
Market cap | SEK 5.64b |
Earnings (TTM) | SEK 151.22m |
Revenue (TTM) | SEK 1.13b |
37.3x
P/E Ratio5.0x
P/S RatioIs RAY B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RAY B income statement (TTM) | |
---|---|
Revenue | SEK 1.13b |
Cost of Revenue | SEK 107.48m |
Gross Profit | SEK 1.02b |
Other Expenses | SEK 869.89m |
Earnings | SEK 151.22m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
Earnings per share (EPS) | 4.41 |
Gross Margin | 90.48% |
Net Profit Margin | 13.40% |
Debt/Equity Ratio | 0% |
How did RAY B perform over the long term?
See historical performance and comparison